Clinical Trials
13 trialsNCT02326064 2025-12-02
TORCH
Centre Hospitalier Departemental Vendee
Completed
NCT05708703 2025-09-16
Assessing the Time Demands of Cancer
Masonic Cancer Center, University of Minnesota
Active not recruiting
NCT02821793 2025-07-01
PRIORITY
Institut Bergonié
Completed
NCT03994653 2025-01-20
CLOCS
Imperial College London
Completed
NCT02825420 2021-10-29
NIMES-ROC
PharmaMar
Completed
NCT04283773 2021-09-08
Immunohistochemical Evaluation of Protein P16 Expression in Ovarian Germ Cell Tumors.
Assiut University
Completed
NCT03593681 2021-01-20
nCYT
Boston Scientific Corporation
Completed
NCT00870233 2018-10-15
Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life
Memorial Sloan Kettering Cancer Center
Completed
NCT01444456 2017-03-20
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
Amgen
Completed
NCT00883181 2017-03-15
A Study of Neutropenia and Anemia Management in Patients With Solid Tumors Receiving Myelotoxic Chemotherapy
Amgen
Completed
NCT01459653 2016-01-11
Monitor-GCSF
Sandoz
Completed
NCT00746694 2015-08-27
A Study to Determine the Management of Palmar-plantar Erythrodysesthesia (PPE) in Patients With Metastatic Ovarian or Breast Cancer Treated With Caelyx (Study P05020)
Merck Sharp & Dohme LLC
Completed
NCT00743431 2015-04-15
Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)
Merck Sharp & Dohme LLC
Completed